Cardiovascular mortality rates declined more among dialysis patients than the general population between 1998 and 2015 in Europe, according to a study published online April 18 in JAMA Network Open.
Apr 19, 2022
0
3
Minutes count when you have a heart attack. Patient involvement is a statutory right but not always possible in this situation. Elise K. Bårdsgjerde has researched participation in the different phases of the patient process ...
Apr 12, 2022
0
12
Smoking cessation adds the same number of heart disease-free years to life as three preventive medications combined, according to research presented at ESC Preventive Cardiology 2022, a scientific congress of the European ...
Apr 7, 2022
0
6
A recent study published in the journal Molecular Therapy - Nucleic Acids on the harmful effects of acute myocardial infarction opens the door to the administration of a molecule (urocortin-2) as a potential treatment to ...
Apr 5, 2022
0
4
Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was classified as non-ST segment ...
Apr 5, 2022
0
32
New results from the North American COVID-19 STEMI (NACMI) registry reported a 25% reduction in early mortality in year 2021 compared to 2020 among patients with ST-segment elevation myocardial infarction (STEMI) and COVID-19 ...
Apr 4, 2022
0
8
The investigational drug vupanorsen reduced total levels of non-high-density lipoprotein (non-HDL) cholesterol by up to 28% in patients with high cholesterol who were already taking a cholesterol-lowering statin medication, ...
Apr 4, 2022
0
13
Compared with a placebo, the addition of the injectable cholesterol-lowering drug alirocumab to high-intensity statin treatment in patients who have had a heart attack resulted in twofold greater reductions in three key measures ...
Apr 4, 2022
0
13
The rate of type 1 acute myocardial infarction (MI) is not increased with receipt of the two-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG vaccine) versus the three-dose hepatitis B vaccine with ...
Apr 1, 2022
0
2
Clinician-scientists in the Smidt Heart Institute at Cedars-Sinai developed a clinical algorithm that, for the first time, distinguishes between treatable sudden cardiac arrest and untreatable forms of the condition.
Mar 30, 2022
0
2
